BioPassport (BIOT) is an incorporated digital platform for personal health records and blockchain healthcare data solutions. As per its whitepaper, the platform aims to deliver a holistic resolution to various corresponding problems within the healthcare industry. The problems have tormented both providers and receivers of healthcare services for decades. The platform seeks to upscale the industry to existing living standards in the age of connectivity to make healthcare a personal element of day-to-day life. Doing so delivers advantages for public health, individual patients, healthcare providers, and personal business organizations.

The outbreak of COVID-19 has underlined the drawbacks of the current healthcare infrastructure, which includes the problems of a timely and coordinated response. Some blame lies in inadequate data control and inadequate access to testing—the problems of the COVID-19 outbreak have been long-standing in healthcare systems worldwide. BioPassport introduced built-in decentralized personal health records (DPHR) to solve the issues. The BioPassport telehealth platform also works as a mobile application with numerous features and functions. BioPassport comes combined with COVID-19 test kits, atopy, and lung cancer, allowing users to participate in remote health monitoring on a model based on subscription. The platform is made around DID (decentralized identity) technology for helping users create their DPHR, permitting accessible, secure, and consistent data management. The layout of the platform accepts user incentives into account.

BIOT token.) is native to the platform. Tokens are earned via interaction with the platform at numerous factors. Tokens are then spent on getting services offered by the platform and the ecosystem or staked on the staking pool. A percentage of the tokens are allocated to the token reward pool for every trade made utilizing tokens. Rewards within the ecosystem are supplied from the pool.

In the fourth quarter of 2020, the BioPassport platform launched a beta service on Android and iOS apps. In the first quarter of 2021, the platform initiated B2B contracts for pharmacies, research labs, hospitals, etc. In the second quarter, the platform officially launched the BioPassport service.